NANCY HOLLOWAY: Open Payments
NPI 1508850942 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 15 payments from 3 companies in 2025. Trend: 2023 $581 · 2024 $621 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $385 |
| COLOPLAST CORP | 2 | $58 |
| ABBVIE INC. | 2 | $49 |
Products named: GEMTESA, BOTOX, Altis, Restorelle.
Industry payments across TX — which companies pay providers there.
